Action Observation and Motor Imagery Therapy in Parkinson's Disease (NCT06154356) | Clinical Trial Compass
RecruitingNot Applicable
Action Observation and Motor Imagery Therapy in Parkinson's Disease
Turkey (Türkiye)54 participantsStarted 2023-12-14
Plain-language summary
In recent years, motor imagery (MI) and action observation (AO) therapy strategies have been used in rehabilitation programs to increase motor learning in Parkinson's disease (PD). Visuomotor training strategies such as AO and MI therapy rely on the activity of the mirror neuron system to facilitate motor re-learning. Mirror neurons are activated during the performance of goal-directed actions, also when observing the same action and visualizing the action in the mind.
The aim of this clinical trial is to test whether the application of AO and MI treatment in PD in addition to conventional rehabilitation programs has an additional effect on Balance, Functional Status and Quality of Life.
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients with a diagnosis of Parkinson's Disease
* Hoehn and Yahr Stage 1-3
Exclusion Criteria:
* Patients with cognitive dysfunction (those who cannot follow simple verbal instructions)
* Patients with severe hearing problems
* Patients with severe vision problems
* Patients with additional musculoskeletal system pathology that will affect physical performance (such as amputation, severe joint mobility limitation, peripheral nerve damage)
* Patients with uncontrolled hypertension and diabetes mellitus
* Patients with a history of symptomatic lung disease (such as asthma, chronic obstructive pulmonary disease, emphysema)
* Patients with a history of symptomatic cardiac disease (such as coronary artery disease, arrhythmia, heart failure)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial uses action observation and motor imagery therapy — meaning watching movements and mentally rehearsing them — rather than hands-on physical therapy. Is this approach something that might actually help my specific stage of Parkinson's, or would a more conventional movement-based rehabilitation program be a better starting point for me?
2The trial is measuring things like balance, the Timed Up and Go Test, and sit-to-stand ability before and after the program. Given where my balance and mobility are right now, do you think I have enough to gain in those areas to make this worth considering?
3Since this trial is listed as Phase NA, which often means it's a non-drug or rehabilitation study without a traditional drug-trial phase, what does that tell us about how much safety and effectiveness data already exists for this type of therapy in Parkinson's patients?
4The trial is tracking changes using the MDS-UPDRS, which covers a broad range of Parkinson's symptoms. Do you think the benefits being measured here align with the symptoms that are bothering me most right now?
5What would participating in this trial actually require of me week to week — in terms of time, travel, or mental effort — and is that realistic given everything else I'm managing with my Parkinson's care?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
The difference in the scores of the Berg Balance Scale between pre- and post-rehabilitation assessments
Timeframe: 6 weeks
2
The difference in the scores of the The Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale pre- and post-rehabilitation assessments
Timeframe: 6 weeks
3
The difference in the scores of the Timed Up and Go Test between pre- and post-rehabilitation assessments
Timeframe: 6 weeks
4
The difference in the scores of the Five Times Sit to Stand Test between pre- and post-rehabilitation assessments